Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.
Gatanaga H, Hayashida T, Tsuchiya K, Yoshino M, Kuwahara T, Tsukada H, Fujimoto K, Sato I, Ueda M, Horiba M, Hamaguchi M, Yamamoto M, Takata N, Kimura A, Koike T, Gejyo F, Matsushita S, Shirasaka T, Kimura S, Oka S.
Gatanaga H, et al. Among authors: kimura a, kimura s.
Clin Infect Dis. 2007 Nov 1;45(9):1230-7. doi: 10.1086/522175. Epub 2007 Sep 24.
Clin Infect Dis. 2007.
PMID: 17918089
Clinical Trial.